JIMD ReportsGenetic & Genomic MedicinePeer-reviewed journal article
Unifying the communities of early-onset glycogen storage disease type IV and adult polyglucosan body disease through a genetic prevalence study of GBE1-related disease
Rebecca L. KochiD, Hasan Orhan AkmaniD, Erin E. ChowniD, Deberah S. Goldman, Jeff Levenson, Qing Ling LuiD, Lindsay T. Michalovicz GilliD, Matthew Morgan, Jennifer L. Orthmann‐MurphyiD, Natacha T Pires, Rebecca ReefiD, Harriet Saxe, Moriel Singer‐BerkiD, Samantha M. BaxteriD
Abstract
Glycogen storage disease type IV (GSD IV) is an autosomal recessive disorder caused by pathogenic variants in GBE1, resulting in deficient glycogen branching enzyme (GBE) activity and formation of abnormal glycogen ("polyglucosan"). GSD IV manifests across a spectrum of clinical dimensions - including hepatic, neurologic, muscular, and cardiac involvement - which vary in severity. The early-onset forms, historically referred to as Andersen disease, present at different stages ranging from in utero to adolescence. The adult-onset form, referred to as adult polyglucosan body disease (APBD), typically presents in middle to late adulthood. To date, no epidemiological study of GSD IV has been performed. Understanding the global prevalence of GSD IV is critical to increase disease awareness, improve diagnostic rates, inform therapeutic development, and engage pharmaceutical companies. In collaboration with the Rare Genomes Project at the Broad Institute of MIT and Harvard and the APBD Research Foundation, this study curated variants in GBE1 and calculated prevalence across nine genetic ancestry groups. The estimated global carrier frequency of GSD IV is 1 in 243 individuals, and the global genetic prevalence is 1 in 235,784 individuals. Based on the 2024 world population, the estimated number of affected individuals with GSD IV is approximately 34,800. These estimates highlight a significant underdiagnosis of GSD IV and underscore the urgent need for increased awareness of this metabolic disorder. This model of collaboration between researchers, patient advocacy organizations, and genetic data sharing programs provides a framework for estimating the prevalence of other rare diseases in the global population. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=180 HEIGHT=200 SRC="FIGDIR/small/25342386v1_ufig1.gif" ALT="Figure 1"> View larger version (49K): org.highwire.dtl.DTLVardef@1a1ad7dorg.highwire.dtl.DTLVardef@1851576org.highwire.dtl.DTLVardef@442c19org.highwire.dtl.DTLVardef@1ab2ddb_HPS_FORMAT_FIGEXP M_FIG Created in BioRender. Koch, R. (2025) https://BioRender.com/j0sg30n. C_FIG
- organism: human
- assay: DNA methylation
- research focus: variant effect prediction
- research focus: benchmarking
- research focus: database / resource
- approach: statistical model
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 21th percentile
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Proteomics profiling of serum and liver in GSD Ia and Ib patients: insights into complication mechanisms and circulation biomarkers
Ruiqi Xiao, Candelas Gross‐Valle, … Justina Clarinda Wolters·Journal of Translational MedicinePeer-reviewed·Feb 20, 2026
- The global prevalence and genetic spectrum of primary carnitine deficiency
Liu Sun, Ke Yao, Hang‐Jing Wu·BMC Genomic DataPeer-reviewed·Jul 7, 2025
- Genetic risk estimates for offspring of patients with Stargardt disease
Stéphanie S. Cornelis, Esmee H. Runhart, … Frans P.M. Cremers·The American Journal of Human GeneticsPeer-reviewed·Feb 3, 2022
- Estimation of the global burden of autosomal recessive rare inborn errors of metabolism
Sorbojit Mondal, Kalyan Goswami, Atanu Kumar Dutta·medRxiv·Feb 14, 2025
- Molecular genetics of GLUT1DS Italian pediatric cohort: 10 novel related-disease variants and structural analysis
Alessia Mauri, Alessandra Duse, … Cristina Cereda·International Journal of Molecular SciencesPeer-reviewed·Nov 4, 2022
- Decoding the Glycan Signature: Unraveling N-Glycosylation Alterations in Glycogen Storage Disease Ia and Ib
Ruiqi Xiao, Jing Zheng, … Guinevere S. M. Lageveen‐Kammeijer·bioRxiv·Oct 23, 2025